Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.8801
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
0.53
Today|||52-Week Range
3.99
+31.95%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 16.50, with a high estimate of 22.00 and a low estimate of 10.00. The median estimate represents a +1,774.79% increase from the last price of 0.88.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.48
Sales
$0.00
Reporting Date
Mar 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.88%
 
 
 
 
 
 
Growthannually 16.82%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.